IKZF1 and acute lymphoblastic leukemia: Patients who did not receive allo-HSCT received maintenance therapy with 6-mercaptopurine and methotrexate with addition of monthly vincristine-dexamethasone pulses, and an additional year of maintenance in IKZF1-deleted ALL.25